VVP
ONC

Venture Visionary Partners’s BeOne Medicines Ltd ONC Stock Holding History

Venture Visionary Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-66
Closed -$10.7K – 1592
2022
Q2 		$10.7K Buy
+66
New +$10.3K ﹤0.01% 1226

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Venture Visionary Partners's ONC Position: Q3 2022 in Review

Venture Visionary Partners sold out of BeOne Medicines Ltd (ONC) in Q3 2022, closing a stake of 66 shares — an estimated $10.7K sold.

Venture Visionary Partners first reported a position in ONC in Q2 2022 and held it in 1 quarter. The position peaked at $10.7K in Q2 2022. 222 funds tracked by Wall St. Rank hold ONC as of Q3 2022.

  • Venture Visionary Partners reported no remaining BeOne Medicines Ltd position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 66 BeOne Medicines Ltd shares in Q3 2022, an estimated $10.7K.
  • Venture Visionary Partners first reported a position in BeOne Medicines Ltd in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's BeOne Medicines Ltd position peaked at $10.7K in Q2 2022.
  • 222 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.